Back to Stocks
Stock detail
Charles River Laboratories International, Inc.
CRLSTOCKS | US | NYSE | Healthcare | Medical - Diagnostics & Research
Profile snapshotUSD 240.4Market cap USD 11.6B
No local candle data found.
Recent detected patterns / setups
Latest 10 Market Radar results for this symbol.
PatternTFDetectedQuality
BullishOliver Kell Momentum Setup15M28 Jul 26, 15:4583
BullishMA 8/21 Crossover15M28 Jul 26, 15:4586
BullishFVG Reaction Setup15M + 15M28 Jul 26, 15:4599
BullishMA 8/21 Crossover4H28 Jul 26, 13:3074
BullishOliver Kell Momentum Setup4H28 Jul 26, 13:3078
BullishFVG Reaction Setup4H + 15M28 Jul 26, 15:4593
BullishMinervini Trend Template4H28 Jul 26, 13:3095
BullishMinervini Trend Template1D28 Jul 26, 00:00100
BullishTriple Bottom15M28 Jul 26, 15:4560
Annual
Annual fundamentals
2025 vs previous annual period
Metric202020212022202320242025
Total revenueUSD 2.9B+11.5%USD 3.5B+21.1%USD 4B+12.3%USD 4.1B+3.9%USD 4B-1.9%USD 4B-0.9%
Net incomeUSD 364.3M+44.6%USD 391M+7.3%USD 486.2M+24.4%USD 474.6M-2.4%USD 10.3M-97.8%USD -144.3M-1501.7%
Net profit margin12.5%+29.6%11.0%-11.4%12.2%+10.7%11.5%-6.0%0.3%-97.8%-3.6%-1513.8%
EPS7.35+42.2%7.77+5.7%9.57+23.2%9.27-3.1%0.2-97.8%-2.91-1555.0%
Quarterly
Quarterly fundamentals
Q1 2026 vs same quarter previous year
MetricQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Total revenueUSD 1B-1.1%USD 984.2M-2.7%USD 1B+0.6%USD 1B-0.5%USD 994.2M-0.8%USD 995.8M+1.2%
Net incomeUSD -215.7M-215.3%USD 25.5M-62.2%USD 52.3M-41.9%USD 54.4M-20.8%USD -276.6M-28.2%USD -14.8M-158.3%
Net profit margin-21.5%-216.6%2.6%-61.1%5.1%-42.2%5.4%-20.4%-27.8%-29.3%-1.5%-157.6%
EPS-4.22-215.6%0.5-61.8%1.06-39.4%1.11-17.2%-5.62-33.2%-0.3-160.0%
Ownership
Institutional ownership summary
2026 Q2, quarter ended 2026-06-30
PeriodOwnershipInstitutions13F sharesTotal investedPositionsPut/call
2026 Q22026-06-30